Puna Bio leverages extremophiles from the Andean salt flats to develop cost-effective bioinputs for agriculture, utilizing their unique ability to thrive in saline and low-light conditions. This innovation promises advancements in sustainable farming, pharmaceuticals, and bioremediation.
Puna Bio is at the cutting edge of agricultural innovation, utilizing extremophiles—organisms that thrive in the harshest environments—to create sustainable bioinputs. These unique microalgae, originating from the high-altitude salt flats of the Puna, are capable of flourishing in low-light and saline conditions. By harnessing these extremophiles, Puna Bio aims to develop novel metabolites with significant potential in agriculture, pharmaceuticals, and bioremediation, revolutionizing traditional farming practices with more sustainable and cost-effective solutions.
The technology focuses on extremophilic microalgae capable of high growth rates in open pond systems using natural sunlight. Key strains include Dunaliella, Nostoc, Anabaena, and Synechocystis. These organisms are screened for their growth in challenging conditions and analyzed for metabolite production using advanced techniques like mass spectrometry and chromatography. Optimization efforts are directed towards maximizing biomass and metabolite yield, assessing biofuel potential, and conducting economic and environmental evaluations.
Puna Bio's technology is currently at Technology Readiness Level 3, indicating that active research and development are underway, with validation efforts focusing on identifying suitable microalgae strains and optimizing cultivation conditions for practical applications.
Puna Bio is an Argentina-based biotechnology startup specializing in regenerative agriculture. Founded in 2020 by scientists, biotechnologists, and agronomists, the company focuses on utilizing extremophile microorganisms to develop sustainable biological inputs that improve crop performance and regenerate soil health. Puna Bio operates internationally with a strong R&D platform and has received backing from major global investors.